Top 50 Most Viewed Posts Last Week |
Today This Week Last Week This Month Last Month
|
1. ohm20: NIH just announced 3 studies to investigate Long (766) (28) |
2. SFLsparky: At least we know Doc is still kicking. That’s (623) (7) |
3. sean007: This arrangement wasn't set up...for Him.. NOT to (604) (5) |
4. Katangolo: Not only that, but Dr Jay pushed back against the (559) (17) |
5. nelsonsjavaheads: That is just an amazing amount of money wasted by (535) (5) |
6. Respert24: I think the answer is a combination of a few (511) (28) |
7. ohm20: CYDY has still not presented viable scientific (504) (23) |
8. Plotinus: Anonymous note to NIH, stop fumbling in the dark. (500) (17) |
9. ohm20: Madrigal's drug for MASH/NASH approved. Well and (499) (20) |
10. Plotinus: Per your link 700,000 Americans have left the (499) (19) |
11. sean007: "Nothing new here"...to Longs...worth a read to (499) |
12. KenChowder: Ohm wrote, Then only allowing two doses in four (488) (26) |
13. chazzledazzle: I’m so glad to hear this. I posted back in (487) (8) |
14. ohm20: I took a look at the study and the supplementary (468) (13) |
15. mountaineer: Up 24% after hours (467) |
16. CGC: Many in the Long Covid activist group agree. And (467) (11) |
17. Charter2024: A lot of uncertainty and frustration at the (458) (12) |
18. sean007: Dr. Bruce Patterson wanted to use (458) (3) |
19. My69z: Dr. J's 2 Vs 4 dosage: pointed it out it in past, (456) (14) |
20. Boatbuilder: Strong financial incentive to take the company to (456) (3) |
21. dfwl28: Apologies if previously posted. Credit Beldar on (454) (8) |
22. dfwl28: Another NIH scientific finding on the significant (453) (6) |
23. ohm20: For those of you in the know, is Leronlimab even (452) (10) |
24. Plotinus: Perhaps Kanecia should wake up and smell the (451) (3) |
25. chazzledazzle: “For those of you in the know, is Leronlimab (447) (11) |
26. Katangolo: Verbal vomit clean up on Aisle 5… As yourself (447) (15) |
27. ohm20: The FDA will assign that to a cohort of doctors (445) (7) |
28. BuckCYDYLong: FWIW, my opinion is that all hope, was placed (444) (4) |
29. Buddyboy20: I figured it is a bonus for hitting his first (423) (2) |
30. mikeyt1818: And we continue to dream.... (422) (11) |
31. Enjay: An update had been posted at Clinical Trials on (421) (9) |
32. HHIGambler: I think it's less "owning the media outlets" and (420) (6) |
33. SFLsparky: That’s definitely his voice. Probably wipes out (418) (4) |
34. KenChowder: Oddly enough, I sent this link and excerpts from (417) (6) |
35. Drano: Madrigal's drug for MASH/NASH approved. There's (416) (3) |
36. chazzledazzle: Mmmm…salt. I knew it was a vitamin. (415) |
37. chazzledazzle: The second publication. Nothing new here, but (414) (3) |
38. Riztheinvestor: Also if anyone has a reasonable explanation for (410) (1) |
39. Charter2024: David's latest Linkin....In answer to the (409) (6) |
40. 2MartiniGi: I think Respert has the right idea. I've been POC (409) (21) |
41. MGK_2: (405) (8) |
42. SFLsparky: I'm still very confident Doc will come through. I (404) (7) |
43. Plotinus: One last footnote on unraveling the mystery (403) (12) |
44. Figgs: So in May 2021 I tried to get LL introduced to (402) (10) |
45. sean007: Well... this is brought to you by the FDA; First (401) (2) |
46. sean007: Madrigal stock drops 29.14 % on the good (399) (3) |
47. skezan: Just wondering who (and what level) in the FDA (398) (3) |
48. ohm20: Right to Try Investigational Drugs not yet (397) (11) |
49. chazzledazzle: Just did a GvHD search for Leronlimab/CCR5 and (396) (3) |
50. Riztheinvestor: Right this absolutely infuriates me every time I (396) (9) |